BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10729170)

  • 1. Naturally occurring TAP-dependent specific T-cell tolerance for a variant of an immunodominant retroviral cytotoxic T-lymphocyte epitope.
    Kim V; Yewdell JW; Green WR
    J Virol; 2000 Apr; 74(8):3924-8. PubMed ID: 10729170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single amino acid variation within an immunodominant AKR/Gross MuLV cytotoxic T-lymphocyte epitope leads to a loss in immunogenicity.
    Kim V; Green WR
    Viral Immunol; 1998; 11(4):197-213. PubMed ID: 10189187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes.
    White HD; Roeder DA; Green WR
    J Virol; 1994 Feb; 68(2):897-904. PubMed ID: 8289392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.
    Sijts AJ; Ossendorp F; Mengedé EA; van den Elsen PJ; Melief CJ
    J Immunol; 1994 Jan; 152(1):106-16. PubMed ID: 8254184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.
    Chen W; Qin H; Chesebro B; Cheever MA
    J Virol; 1996 Nov; 70(11):7773-82. PubMed ID: 8892898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of proximal and distal sequence variations in the presentation of an immunodominant CTL epitope encoded by the ecotropic AK7 MuLV.
    Kim V; Green WR
    Virology; 1997 Sep; 236(2):221-33. PubMed ID: 9325230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.
    Ossendorp F; Eggers M; Neisig A; Ruppert T; Groettrup M; Sijts A; Mengedë E; Kloetzel PM; Neefjes J; Koszinowski U; Melief C
    Immunity; 1996 Aug; 5(2):115-24. PubMed ID: 8769475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major and minor Kb-restricted epitopes encoded by the endogenous ecotropic murine leukemia virus AKR623 that are recognized by anti-AKR/Gross MuLV CTL.
    White HD; Roeder DA; Lam T; Green WR
    Viral Immunol; 1994; 7(2):51-9. PubMed ID: 7848510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte responses to the envelope proteins of endogenous ecotropic and mink cytopathic focus-forming murine leukemia viruses in H-2b mice.
    Coppola MA; Green WR
    Virology; 1994 Jul; 202(1):500-5. PubMed ID: 7516600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness.
    Smith PM; Rich RF; Green WR
    Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.
    Iezzi G; Rivolta L; Ronchetti A; Martin-Fontecha A; Rosato A; Protti MP; Sabbadini MG; Bellone M
    Cancer Res; 1997 Jul; 57(13):2564-8. PubMed ID: 9205054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillance.
    Facchinetti A; Dalla Santa S; Mezzalira S; Rosato A; Biasi G
    J Immunol; 2005 May; 174(9):5398-406. PubMed ID: 15843538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.
    Schell TD; Mylin LM; Georgoff I; Teresky AK; Levine AJ; Tevethia SS
    J Virol; 1999 Jul; 73(7):5981-93. PubMed ID: 10364350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.
    Fu TM; Mylin LM; Schell TD; Bacik I; Russ G; Yewdell JW; Bennink JR; Tevethia SS
    J Virol; 1998 Feb; 72(2):1469-81. PubMed ID: 9445050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.
    Milan G; Zambon A; Cavinato M; Zanovello P; Rosato A; Collavo D
    J Virol; 1999 Mar; 73(3):2280-7. PubMed ID: 9971811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.
    Lukacher AE; Wilson CS
    J Immunol; 1998 Feb; 160(4):1724-34. PubMed ID: 9469430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin.
    van Hall T; van Bergen J; van Veelen PA; Kraakman M; Heukamp LC; Koning F; Melief CJ; Ossendorp F; Offringa R
    J Immunol; 2000 Jul; 165(2):869-77. PubMed ID: 10878361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.
    Sette AD; Oseroff C; Sidney J; Alexander J; Chesnut RW; Kakimi K; Guidotti LG; Chisari FV
    J Immunol; 2001 Jan; 166(2):1389-97. PubMed ID: 11145724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
    Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
    J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.